Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism NR4A2 agonists(nuclear receptor subfamily 4 group A member 2 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neurodegenerative Diseases | Preclinical | DE | 25 Feb 2021 | |
Neurodegenerative Diseases | Preclinical | DE | 25 Feb 2021 |